Covered recipient · General Payments record
LAUREN A GIRARD
Allopathic & Osteopathic Physicians Family Medicine
General Payments · PY2019–2024
$2,296.64
- Reported across 72 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2024 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $1,138.94 | 26 |
| Education | $32.27 | 1 |
By paying entity
PY2024 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| ABBVIE INC. | $720.49 | 13 |
| Amgen Inc. | $139.11 | 2 |
| Lilly USA, LLC | $115.96 | 2 |
| Novo Nordisk AS | $69.76 | 3 |
| Acerta Pharma LLC | $56.46 | 3 |
| Abbott Laboratories | $33.94 | 2 |
| Exact Sciences Corporation | $20.23 | 1 |
| Averitas Pharma Inc. | $15.26 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2024 (27)
Sorted by paying entity, then date · as published by CMS
Program year 2024 20192020202120222023
Record-level detail is published for PY2024; earlier years are summarised in
“By program year”.
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| Abbott Laboratories | $16.97 | 06/13/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1125003056 | CMS |
| Abbott Laboratories | $16.97 | 07/29/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1125003058 | CMS |
| ABBVIE INC. | $115.47 | 01/11/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103801294 | CMS |
| ABBVIE INC. | $13.11 | 04/29/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103801296 | CMS |
| ABBVIE INC. | $21.50 | 05/21/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103801298 | CMS |
| ABBVIE INC. | $60.23 | 05/21/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103801300 | CMS |
| ABBVIE INC. | $46.85 | 05/21/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103801302 | CMS |
| ABBVIE INC. | $117.48 | 05/21/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103801304 | CMS |
| ABBVIE INC. | $113.93 | 06/25/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103801306 | CMS |
| ABBVIE INC. | $22.96 | 09/28/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103801308 | CMS |
| ABBVIE INC. | $28.96 | 09/28/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103801310 | CMS |
| ABBVIE INC. | $25.00 | 11/02/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103801312 | CMS |
| ABBVIE INC. | $60.00 | 11/02/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103801314 | CMS |
| ABBVIE INC. | $25.00 | 11/02/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103801316 | CMS |
| ABBVIE INC. | $70.00 | 11/02/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103801318 | CMS |
| Amgen Inc. | $120.83 | 08/29/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1111584230 | CMS |
| Amgen Inc. | $18.28 | 12/18/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1117261263 | CMS |
| AstraZeneca Pharmaceuticals LP | $22.05 | 07/24/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1104658097 | CMS |
| AstraZeneca Pharmaceuticals LP | $19.05 | 08/07/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1104689970 | CMS |
| AstraZeneca Pharmaceuticals LP | $15.36 | 10/11/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105207801 | CMS |
| Averitas Pharma Inc. | $15.26 | 08/28/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1133427243 | CMS |
| Exact Sciences Corporation | $20.23 | 12/04/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1114413886 | CMS |
| Lilly USA, LLC | $19.29 | 05/15/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1135148494 | CMS |
| Lilly USA, LLC | $96.67 | 05/30/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1135144083 | CMS |
| Novo Nordisk Inc | $18.71 | 06/06/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1097205930 | CMS |
| Novo Nordisk Inc | $32.27 | 07/11/2024 | Education | Undisputed | 01/23/2026 | 1096640140 | CMS |
| Novo Nordisk Inc | $18.78 | 09/25/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1096760282 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2019, 2020, 2021, 2022, 2023, 2024
- Generated from
- OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.